Nitrogen retention in urban lawns and forests.

Lawns are a dominant cover type in urban ecosystems, and there is concern about their impacts on water quality. However, recent watershed-level studies suggest that these pervious areas might be net sinks, rather than sources, for nitrogen (N) in the urban environment. A 15N pulse-labeling experiment was performed on lawn and forest plots in the Baltimore (Maryland, U.S.A.) metropolitan area to test the hypothesis that lawns are a net sink for atmospheric-N deposition and to compare and contrast mechanisms of N retention in these vegetation types. A pulse of 15N-NO3-, simulating a precipitation event, was followed through mineral soils, roots, Oi-layer/thatch, aboveground biomass, microbial biomass, inorganic N, and evolved N2 gas over a one-year period. The 15N label was undetectable in gaseous samples, but enrichment of other pools was high. Gross rates of production and consumption of NO3- and NH4+ were measured to assess differences in internal N cycling under lawns and forests. Rates of N retention were similar during the first five days of the experiment, with lawns showing higher N retention than forests after 10, 70, and 365 days. Lawns had larger pools of available NO3- and NH4+; however, gross rates of mineralization and nitrification were also higher, leading to no net differences in NO3- and NH4+ turnover times between the two systems. Levels of 15N remained steady in forest mineral soils from day 70 to 365 (at 23% of applied 15N), but continued to accumulate in lawn mineral soils over this same time period, increasing from 20% to 33% of applied 15N. The dominant sink for N in lawn plots changed over time. Immobilization in mineral soils dominated immediately (one day) after tracer application (42% of recovered 15N); plant biomass dominated the short term (10 days; 51%); thatch and mineral-soil pools together dominated the medium term (70 days; 28% and 36%, respectively); and the mineral-soil pool alone dominated long-term retention (one year; 70% of recovered 15N). These findings illustrate the mechanisms whereby urban and suburban lawns under low to moderate management intensities are an important sink for atmospheric-N deposition.

[Epidural spinal stimulation in the treatment of refractory angina pectoris. Its clinical efficacy, complications and long-term mortality. An Italian multicenter retrospective study]. / La stimolazione spinale epidurale nel trattamento dell'angina pectoris refrattaria. Efficacia clinica, complicanze e mortalità a lungo termine. Studio retrospettivo multicentrico Italiano.

BACKGROUND: Spinal cord stimulation has been used for many years in the treatment of refractory angina pectoris. Its anti-anginal and anti-ischemic effect has been well documented in several studies, but the long-term efficacy, safety and survival rate are not well known. The aim of this study was to carry out a retrospective analysis of a series of patients from the Italian Multicenter Registry, the data of which were collected in five centers, by means of a questionnaire. METHODS: One hundred and thirty patients (83 males, 47 females, mean age 74.8 +/- 9.8 years) were submitted to spinal cord stimulator implantation for refractory angina pectoris in the period 1988-1995 and controlled during a mean follow-up of 31.4 +/- 25.9 months. A previous myocardial infarction had already occurred in 69.3% of patients, whereas in 67.6% multivessel coronary artery disease was documented. A left ventricular dysfunction (ejection fraction < 0.40) was present in 34% of patients; bypass surgery and coronary angioplasty were performed in 49.6% and in 27% of patients respectively. In 96.3% of cases revascularization procedures were not advisable. RESULTS: A complete follow-up of 116 patients (89.2%) was available. The spinal cord stimulator induced a significant reduction in NYHA functional class from 2.5 +/- 1.2 to 1.5 +/- 0.9 (p < 0.01). During the follow-up 41 patients (35.3%) died, and in 14.2% a new acute myocardial infarction developed. The total percentage of minor spinal cord stimulation-related complications was 6.8%. No major complications occurred. The annual total mortality rate was 6.5%, whereas the cardiac mortality rate was 5%. Compared to the survivors, patients who died showed a higher incidence of left ventricular dysfunction, previous myocardial infarction and bypass surgery at implantation. CONCLUSIONS: In our experience, spinal cord stimulation is an effective therapy in patients affected by refractory angina pectoris and who cannot undergo revascularization procedure. The complication rate is low, with the total and cardiac mortality showing a trend as that reported for patients with similar coronary disease.

Captopril at 50 mg as well as at 100 mg once a day reduces blood pressure for up to 24 h: a double-blind randomized crossover study in mild to moderate hypertensives.

The extent and the duration of the antihypertensive effect of captopril, given once a day at a dose of 50 mg, compared with placebo and with the 100 mg once daily dose was studied in 30 mild or moderate uncomplicated essential hypertensives (mean +/- s.e.m. age 52.0 +/- 1.5 years), who responded (mean blood pressure decrease greater than 10%) to a single oral dose (12.5 mg) of captopril. According to a randomized, double-blind, crossover design, they were given 50 mg captopril four times a day, 100 mg captopril four times a day or matched placebo for 1 month. At the end of each treatment period blood pressure and heart rate were measured every 30 min from 3 h before to 2 h after the last dose. Although the heart rate did not change, mean blood pressure after the 50- and 100-mg doses of captopril was consistently significantly (P less than or equal to 0.05) lower than after placebo. The hypotensive effect peaked at the second hour and was still significant 24 h after dosing without any significant differences between the 50- and the 100-mg doses. These findings indicate that captopril, given chronically once a day at a dose of 50 mg to mild to moderate hypertensive responders, exerts its hypotensive effect up to 24 h and that doubling the dose does not increase either the extent or the duration of its action.